Drug repositioning for treatment of movement disorders: from serendipity to rational discovery strategies.
Movement disorders are a heterogeneous group of both common and rare neurological conditions characterized by abnormalities of motor functions and movement patterns. This work overviews recent successes and ongoing studies of repositioning relating to this disease group, which underscores the challenge of integrating the voluminous and heterogeneous findings required for making suitable drug repositioning decisions. In silico drug repositioning methods hold the promise of automated fusion of heterogeneous information sources, but the controllable, flexible and transparent incorporation of the expertise of medicinal chemists throughout the repositioning process remains an open challenge. In support of a more systematic approach toward repositioning, we summarize the application of a computational repurposing method based on statistically rooted knowledge fusion. To foster the spread of this technique, we provide a step-by-step guide to the complete workflow, together with a case study in Parkinson's disease.
Department of Measurement and Information Systems, Budapest University of Technology and Economics H-1521, Budapest, Magyar tudosok krt. 2, Hungary. matyus.peter@pharma.semmelweis-univ.hu.
Bence
B
Bolgár
Ádám
Á
Arany
Gergely
G
Temesi
Balázs
B
Balogh
Péter
P
Antal
Péter
P
Mátyus
D000818:Animals; D055808:Drug Discovery; D058492:Drug Repositioning; D006801:Humans; D009069:Movement Disorders / Q000188:drug therapy*